Martin Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,484
Closed -$228K 49
2025
Q4
$228K Sell
4,484
-270,722
-98% -$13.8M 0.06% 47
2025
Q3
$15.3M Sell
275,206
-1,541
-0.6% -$90.2K 3.88% 11
2025
Q2
$19.1M Sell
276,747
-12,236
-4% -$832K 4.9% 9
2025
Q1
$20.1M Buy
288,983
+6,820
+2% +$563K 5.06% 7
2024
Q4
$24.3M Sell
282,163
-10,256
-4% -$1.11M 6.66% 2
2024
Q3
$34.8M Buy
292,419
+5,207
+2% +$694K 8.52% 1
2024
Q2
$41M Sell
287,212
-9,569
-3% -$1.27M 10.52% 1
2024
Q1
$38.1M Buy
296,781
+9,315
+3% +$1.11M 9.36% 1
2023
Q4
$29.7M Sell
287,466
-3,602
-1% -$356K 8.86% 1
2023
Q3
$26.5M Sell
291,068
-7,728
-3% -$681K 7.93% 1
2023
Q2
$24.2M Buy
+298,796
New +$24.4M 6.82% 2
2016
Q3
Sell
-9,790
Closed -$263K 39
2016
Q2
$263K Buy
9,790
+160
+2% +$4.39K 0.04% 39
2016
Q1
$261K Buy
+9,630
New +$258K 0.04% 39
2014
Q4
Sell
-11,090
Closed -$264K 50
2014
Q3
$264K Buy
+11,090
New +$255K 0.05% 48
2014
Q2
Sell
-10,000
Closed -$228K 51
2014
Q1
$228K Buy
+10,000
New +$213K 0.04% 47

Other funds holding NVO

Martin Investment Management's NVO Position: Q1 2026 in Review

Martin Investment Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,484 shares — an estimated $228K sold.

Martin Investment Management first reported a position in NVO in Q1 2014 and held it in 15 quarters. The position peaked at $41M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Martin Investment Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Martin Investment Management sold 4,484 Novo Nordisk shares in Q1 2026, an estimated $228K.
  • Martin Investment Management first reported a position in Novo Nordisk in Q1 2014 and held it in 15 quarters.
  • Martin Investment Management's Novo Nordisk position peaked at $41M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Martin Investment Management's 13F filing for Q1 2026, filed 13 May 2026.